Lymphocyte proliferation in vitro induced by hapten autologous protein conjugates. I. A study on the class of lymphocytes responding in vitro and on the nature and specificity of their receptors.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 2139556)

Published in J Exp Med on March 01, 1974

Authors

B Rubin, H Wigzell

Articles cited by this

A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86

Immunological specificity of delayed and immediate hypersensitivity reactions. J Exp Med (1962) 10.99

Studies of hypersensitivity to low molecular weight substances. III. The 2,4-dinitrophenyl group as a determinant in the preciptin reaction. J Immunol (1954) 7.50

Cell selection by antigen in the immune response. Adv Immunol (1969) 6.05

Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin. J Exp Med (1971) 5.43

Cell separation on antigen-coated columns. Elimination of high rate antibody-forming cells and immunological memory cells. J Exp Med (1969) 5.38

AN IN VITRO SYSTEM FOR THE STUDY OF THE MECHANISM OF ANTIGENIC STIMULATION IN THE SECONDARY RESPONSE. Immunology (1964) 5.36

Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide. Cell Immunol (1971) 4.69

Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55

The peritoneal exudate lymphocyte. I. Differences in antigen responsiveness between peritoneal exudate and lymph node lymphocytes from immunized guinea pigs. J Exp Med (1971) 3.81

The immunologic significance of antigen induced lymphocyte transformation in vitro. J Immunol (1966) 3.79

Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens. J Exp Med (1970) 3.08

Synergistic interaction of macrophages and lymphocytes in antigen-induced transformation of lymphocytes. J Exp Med (1970) 3.08

Studies on hypersensitivity. IV. The relationship between contact and delayed sensitivity: a study of the specificity of cellular immune reactions. J Exp Med (1961) 3.07

Genetic control of the immune response. The effect of thymectomy on the primary and secondary antibody response of mice to poly-L(tyr, glu)-poly-D, L-ala--poly-L-lys. J Exp Med (1972) 3.06

Studies on actively allergized cells. I. The cyto-dynamics and morphology of rosete-forming lymph node cells in mice and inhibition of rosette-formation with antibody to mouse immunoglobulins. Int Arch Allergy Appl Immunol (1969) 3.00

Specificity of cellular immune responses. Antigen concentration dependence of stimulation of DNA synthesis in vitro by specifically sensitized cells, as an expression of the binding characteristics of cellular antibody. J Exp Med (1968) 2.32

Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes. J Exp Med (1971) 2.09

Receptors on immunocompetent cells. V. Cellular correlates of the "maturation" of the immune response. J Exp Med (1972) 2.03

Specific separation of cells on affinity columns. Proc Natl Acad Sci U S A (1970) 2.01

Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol (1971) 1.80

Receptors on immunocompetent cells. I. Receptor specificity of cells participating in a cellular immune response. Cell Immunol (1970) 1.70

Cell cooperation in antibody induction. The susceptibility of helper cells to specific lethal radioactive antigen. Eur J Immunol (1971) 1.64

Modulation of in vitro lymphocyte transformation by antibodies: enhancement by antigen-antibody complexes and inhibition by antibody excess. Cell Immunol (1972) 1.56

Some physical and radiobiological properties of immunologically reactive mouse spleen cells. J Exp Med (1970) 1.55

Interaction of immune lymphocytes with the mixtures of target cells possessing selected specificities of the H-2 immunizing allele. Immunology (1971) 1.42

Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells. J Immunol (1971) 1.40

Identification by density separation of antigen-specific surface receptors on the progenitors of antibody-producing cells. Immunology (1971) 1.35

Antigen-macrophage interaction. II. Relative roles of cytophilic antibody and other membrane sites. J Immunol (1973) 1.32

Identification of two cell populations required for mouse immunocompetence. J Immunol (1970) 1.31

T and B rosette-forming cells. Eur J Immunol (1971) 1.29

Cellular immunoabsorbents in transplantation immunity. Specific in vitro deletion and recovery of mouse lymphoid cells sensitized against allogeneic tumors. J Exp Med (1972) 1.27

In vitro induction of specific unresponsiveness of immunologically reactive, normal bone marrow cells. J Exp Med (1970) 1.23

The relationship of antibody-forming cells to rosette-forming cells. Immunology (1971) 1.20

Haptenated bacteriophage in the assay of antibody quantity and affinity: maturation of an immune response. Immunochemistry (1970) 1.14

The immune response against hapten-autologous protein conjugates in the mouse. J Exp Med (1973) 1.12

Heterogeneity of the cellular immune response. I. Kinetics of lymphocyte stimulation during sensitization and recovery from tolerance. J Exp Med (1971) 1.08

Proliferation by bone marrow-derived lymphocytes in response to antigenic stimulation in vitro. J Immunol (1972) 1.04

Studies on the induction of antibody synthesis against sulfanilic acid in rabbits. I. Effect of the number of hapten molecules introduced in homologous protein on antibody synthesis against the hapten and the new antigenic determinants. Eur J Immunol (1972) 1.04

Hapten-reactive helper lymphocytes. Nature (1973) 1.03

Cytotoxic immune cells with specificity for defined soluble antigens. II. Chasing the killing cells. Cell Immunol (1973) 0.98

Impact of fractionation procedures on lymphocyte activities in vitro and in vivo. Separation of cells with high concentrations of surface immunoglobin. Transplant Proc (1972) 0.93

Dose- and time-dependent changes in the binding capacity of IgM antibody. Eur J Immunol (1972) 0.93

Hapten specificity of cellular immune responses as compared with the specificity of serum anti-hapten antibody. Immunology (1970) 0.91

Defective in vitro spleen cell proliferative response to antigens in agammaglobulinemic chickens. J Immunol (1972) 0.90

Antigen-macrophage interaction. I. Hapten-specific inhibition of antigen interaction with macrophages from immune animals. J Immunol (1973) 0.87

Inhibition of antigen-stimulated in vitro proliferation of thymic dependent chicken spleen cells by specific antibody. J Immunol (1972) 0.86

Affinity and Ig classes of anti-hapten antibodies in carrier-preimmunized rats. Eur J Immunol (1973) 0.86

Antigen-induced lymphocyte transformation in vitro during primary immunization in man. 1. Development and course. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 0.83

A cell population study of IgM affinity maturation. Cell Immunol (1973) 0.81

Effect of specific antibody on the antigen-induced proliferative response of rabbit lymph node cells. J Immunol (1973) 0.80

Quantity and quality of anti-hapten antibodies in normal and in T cell-deprived mice studied at the cellular level. Scand J Immunol (1972) 0.77

Articles by these authors

(truncated to the top 100)

Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med (1972) 24.43

"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 7.61

Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res (1968) 7.53

Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science (1977) 5.39

Cell separation on antigen-coated columns. Elimination of high rate antibody-forming cells and immunological memory cells. J Exp Med (1969) 5.38

"Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol (1975) 4.86

Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev (1972) 4.71

Antibody synthesis at the cellular level. Antibody-induced suppression of 7S antibody synthesis. J Exp Med (1966) 4.49

Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. Lancet (1972) 4.36

The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82

Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature (1978) 3.72

Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T-cell receptors with specificity for the same alloantigens. J Exp Med (1975) 3.63

Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem (2000) 3.59

Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen. Scand J Immunol (1972) 3.52

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A (1987) 3.47

Two different VH gene products make up the T-cell receptors. Scand J Immunol (1976) 3.32

An analysis of the murine NK cell as to structure, function and biological relevance. Immunol Rev (1979) 3.15

Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol (1976) 3.13

Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med (2001) 3.11

The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood (2000) 3.09

Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens. J Exp Med (1970) 3.08

Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol (1977) 3.05

Antigen-binding, idiotypic T-lymphocyte receptors. Contemp Top Immunobiol (1977) 3.00

Cells mediating specific in vitro cytotoxicity. II. Probable autonomy of thymus-processed lymphocytes (T cells) for the killing of allogeneic target cells. J Exp Med (1972) 3.00

Evidence for an immunoglobulin-dependent antigen-specific helper T cell. Proc Natl Acad Sci U S A (1977) 2.72

Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum (1986) 2.56

Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev (1973) 2.53

Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci U S A (1993) 2.49

Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest (1972) 2.39

Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature (1977) 2.39

Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. II. Determination of frequency and characteristics of idiotypic T and B lymphocytes in normal rats using direct visualization. J Exp Med (1975) 2.34

Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci U S A (1983) 2.33

Molteno implants as a treatment for refractory glaucoma in black patients. Arch Ophthalmol (1991) 2.33

Specific transplantation tolerance induced by autoimmunization against the individual's own, naturally occurring idiotypic, antigen-binding receptors. J Exp Med (1976) 2.29

Long term growth in vitro of human T cell blasts with maintenance of specificity and function. J Immunol (1979) 2.25

In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J Exp Med (1972) 2.13

TIP47 associates with lipid droplets. J Biol Chem (2000) 2.13

Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med (1976) 2.11

Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology (1987) 2.11

Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes. J Exp Med (1971) 2.09

Specific fractionation of immunocompetent cells. Transplant Rev (1970) 2.04

The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol (1979) 2.02

Demonstration of heavy and light chain antigenic determinants on the cell-bound receptor for antigen. Similarities between membrane-attached and humoral antibodies produced by the same cell. J Exp Med (1970) 2.01

Insights into interfacial activation from an open structure of Candida rugosa lipase. J Biol Chem (1993) 1.99

Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99

T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol (1985) 1.96

Studies at the cellular level of the 19S immune response. Acta Pathol Microbiol Scand (1966) 1.93

Analysis of clinical specimens by hybridisation with probe containing repetitive DNA from Plasmodium falciparum. A novel approach to malaria diagnosis. Lancet (1984) 1.92

Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies. J Exp Med (1982) 1.74

Prostaglandin antagonists: synthesis and smooth muscle activity. Nature (1969) 1.72

Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. J Immunol (1990) 1.69

T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type. J Exp Med (1991) 1.69

Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector. Proc Natl Acad Sci U S A (1988) 1.66

A simple rosette assay for demonstration of complement receptor sites using complement-coated zymosan beads. Eur J Immunol (1976) 1.66

Resistance to broomrape (Orobanche spp.) in sunflower (Helianthus annuus L.) is temperature dependent. J Exp Bot (2003) 1.64

Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation (2001) 1.63

Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. V. Biochemical and serological characteristics of naturally occurring, soluble antigen-binding T-lymphocyte-derived molecules. Scand J Immunol (1976) 1.63

Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun (1993) 1.59

Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytolytic ability for antibody-coated tumour target cells. Scand J Immunol (1978) 1.58

Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol (1983) 1.58

T-cell idiotypes are linked to immunoglobulin heavy chain genes. Nature (1976) 1.55

Getting teams to talk: development and pilot implementation of a checklist to promote interprofessional communication in the OR. Qual Saf Health Care (2005) 1.55

Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J (1997) 1.54

Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci U S A (1996) 1.54

Labeled staphylococcal protein A as an immunological probe in the analysis of cell surface markers. Scand J Immunol (1974) 1.52

A radioimmunoassay of cellular surface antigens on living cells using iodinated soluble protein A from Staphylococcus aureus. J Immunol Methods (1975) 1.50

Relationship between HLA-DR-expressing cells and T lymphocytes of different subsets in rheumatoid synovial tissue. Scand J Immunol (1981) 1.48

Production of IL 2 and IFN-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol (1985) 1.46

Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A (1990) 1.46

Function and distribution pattern of human T lymphocytes. I. Production of anti-T lymphocyte specific sera as estimated by cytotoxicity and elimination of function of lymphocytes. Clin Exp Immunol (1973) 1.46

Surgace IgM specificity on cells derived from a Burkitt's lymphoma. Lancet (1967) 1.46

Immune responses against native and chemically modified albumins in mice. I. Analysis of non-thymus-processed (B) and thymus-processed (T) cell responses against methylated bovine serum albumin. J Exp Med (1972) 1.45

Natural killer cells kill tumour cells at a given stage of differentiation. Nature (1981) 1.43

T cell receptors with allo-major histocompatibility complex specificity from rat and mouse. Similarity of size, plasmin susceptibility, and localization of antigen-binding region. J Exp Med (1981) 1.42

Immune responses in spleen colonies. II. Clonal assortment of 19S- and 7S-producing cells in mice reacting against two antigens. Immunology (1966) 1.41

DNA hybridization assays for detection of malarial sporozoites in mosquitoes. Parasitol Today (1987) 1.40

The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. Arthritis Rheum (1986) 1.39

Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol (1999) 1.39

Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes. Eur J Immunol (1991) 1.39

Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children. J Immunol (1981) 1.38

Cytotoxic T lymphocyte membrane components: an analysis of structures related to function. Contemp Top Mol Immunol (1977) 1.38

Cell surface glycoproteins of murine cytotoxic T lymphocytes. I. T 145, a new cell surface glycoprotein selectively expressed on Ly 1-2+ cytotoxic T lymphocytes. J Exp Med (1978) 1.38

NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J (1995) 1.38

Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med (1999) 1.37

Polymerase chain reaction, virus isolation and antigen assay in HIV-1-antibody-positive mothers and their children. AIDS (1991) 1.37

Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides. Proc Soc Exp Biol Med (1972) 1.37

Antigen-binding, idiotypic receptors from T lymphocytes: an analysis of their biochemistry, genetics, and use as immunogens to produce specific immune tolerance. Cold Spring Harb Symp Quant Biol (1977) 1.36

Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur J Immunol (1992) 1.35

Cell-bound receptors for alloantigens on normal lymphocytes. II. Antialloantibody serum contains specific factors reacting with relevant immunocompetent T lymphocytes. J Exp Med (1974) 1.35

Sensitization of human lymphocytes against autologous or allogeneic lymphoblastoid cell lines: characteristics of the reactive cells. Scand J Immunol (1974) 1.35

Cholecystokinin-pancreozymin: recent developments. Am J Dig Dis (1970) 1.33

IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J Immunol (2001) 1.32

Multiple activities of a cloned cell line mediating natural killer cell function. J Exp Med (1981) 1.31

Immune responses against native and chemically modified albumins in mice. II. Effect of electric charge and conformation on the humoral antibody response and on helper T cell responses. J Immunol (1974) 1.31

Specific affinity fractionation of lymphocytes using glass or plastic bead columns. Scand J Immunol (1976) 1.30

H-2-linked gene(s) influence the granulomatous reaction to viable Mycobacterium lepraemurium in the mouse. Scand J Immunol (1983) 1.29

Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J Immunol (2000) 1.29

Immune functions of human synovial cells. Phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR. Arthritis Rheum (1982) 1.29

The immune response against hapten-autologous protein conjugates in the mouse. I. Specificity of antibodies produced during the primary response against dinitrophenylated mouse serum albumin. Eur J Immunol (1973) 1.27

T cells specific for hapten-modified self are precommitted for self major histocompatibility complex antigens before encounter with the hapten. J Exp Med (1978) 1.27